Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NCL: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
NCL is a gene implicated in neurodegeneration research. Key relationships include: involved in, activates, regulates. Associated with Als, Alzheimer's Disease, Autoimmune Diseases. Connected to 32 entities in the SciDEX knowledge graph.
| Gene Symbol | NCL |
| Full Name | Nucleolin |
| Chromosome | 2q37.1 |
| Function | Nucleolin performs diverse cellular functions |
| Primary Expression | Nucleolus, Brain (neurons, hippocampus, cortex) |
| Pathways | Microrna |
| UniProt ID | P19367 |
| NCBI Gene ID | 4690 |
| Ensembl ID | ENSG00000115053 |
| OMIM | 164035 |
| GeneCards | NCL |
| Human Protein Atlas | NCL |
| Protein | Nucleolin Protein |
| Associated Diseases | ALS, Alzheimer's Disease, Autoimmune Diseases, Viral Infections, neurodegeneration |
| Interactions | TRIM2, SQSTM1, TPP1, ERK, BECN1, AIF1 |
| KG Connections | 74 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
NCL["NCL (Nucleolin)"]
%% Core cellular processes
NCL -->|"regulates"| RNA_Transcription["RNA Transcription"]
NCL -->|"processes"| rRNA_Processing["rRNA Processing"]
NCL -->|"stabilizes"| mRNA_Stabilization["mRNA Stabilization"]
NCL -->|"facilitates"| DNA_Replication["DNA Replication"]
NCL -->|"remodels"| Chromatin_Remodeling["Chromatin Remodeling"]
%% Gene regulation
NCL -->|"regulates"| HIPPO["HIPPO Pathway"]
NCL -->|"controls"| MicroRNA["MicroRNA Processing"]
NCL -->|"activates"| ERK["ERK Signaling"]
%% Cell fate processes
RNA_Transcription -->|"promotes"| Cell_Proliferation["Cell Proliferation"]
NCL -->|"upregulates"| Cell_Proliferation
NCL -->|"modulates"| Apoptosis["Apoptosis"]
Cell_Proliferation -->|"leads to"| Cytokinesis["Cytokinesis"]
%% Neurodegeneration context
NCL -->|"associated with"| Alzheimers["Alzheimer's Disease"]
NCL -->|"therapeutic target"| ALS["ALS"]
%% Pathological outcomes
ERK -->|"promotes"| Invasion["Cell Invasion"]
NCL -->|"activates"| Cancer["Cancer/Carcinoma"]
Cell_Proliferation -->|"contributes to"| Cancer
%% Styling
style NCL fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px
style rRNA_Processing fill:#1b5e20,stroke:#2e7d32
style mRNA_Stabilization fill:#1b5e20,stroke:#2e7d32
style HIPPO fill:#4a1a6b,stroke:#7b1fa2
style ERK fill:#4a1a6b,stroke:#7b1fa2
style Alzheimers fill:#7d4200,stroke:#ef6c00
style ALS fill:#7d4200,stroke:#ef6c00
style Cancer fill:#ef5350,stroke:#c62828
style Apoptosis fill:#1b5e20,stroke:#2e7d32| Target | Relation | Type | Str |
|---|---|---|---|
| Histone Chaperone Activity | mediates | mechanism | 0.95 |
| MADD | regulates | protein | 0.95 |
| iCCA cell proliferation | promotes | process | 0.93 |
| Chromatin Remodeling | involved_in | process | 0.90 |
| RNA Transcription | regulates | process | 0.90 |
| Histone Chaperone Activity | involved_in | process | 0.90 |
| Gene Expression | regulates | process | 0.90 |
| Cancer | biomarker_for | disease | 0.90 |
| DNA recombination | regulates | process | 0.85 |
| cancer cell proliferation | drives | phenotype | 0.85 |
| Cancer | upregulates | disease | 0.85 |
| DNA Recombination | involved_in | process | 0.80 |
| DNA Replication | involved_in | process | 0.80 |
| rRNA Processing | involved_in | process | 0.80 |
| mRNA Stabilization | involved_in | process | 0.80 |
| Cell Proliferation | upregulates | process | 0.80 |
| Cytokinesis | involved_in | process | 0.80 |
| apoptosis | regulates | process | 0.80 |
| neurons | expressed_in | cell_type | 0.80 |
| drug resistance | contributes_to | phenotype | 0.75 |
| Alzheimer's Disease | implicated_in | disease | 0.75 |
| Viral Infections | associated_with | disease | 0.70 |
| Autoimmune Diseases | associated_with | disease | 0.70 |
| viral infections | implicated_in | disease | 0.70 |
| autoimmune diseases | implicated_in | disease | 0.70 |
| Apoptosis | involved_in | process | 0.70 |
| Alzheimer's Disease | associated_with | disease | 0.70 |
| Drug Resistance | involved_in | phenotype | 0.70 |
| autophagy pathway | participates_in | pathway | 0.70 |
| Als | therapeutic_target | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| TRIM2 | inhibits | gene | 0.60 |
| neurodegeneration | causes | disease | 0.60 |
| SQSTM1 | interacts_with | gene | 0.60 |
| TPP1 | interacts_with | gene | 0.60 |
| HIPPO | regulates | gene | 0.60 |
| GENES | regulates | gene | 0.60 |
| Hippo Pathway | therapeutic_target | pathway | 0.60 |
| Differentiation | therapeutic_target | pathway | 0.60 |
| Microrna | regulates | pathway | 0.60 |
| ERK | activates | gene | 0.60 |
| Invasion | activates | pathway | 0.60 |
| Rna Splicing | activates | pathway | 0.60 |
| Mapk | activates | pathway | 0.60 |
| Erk Signaling | activates | pathway | 0.60 |
| Glycolysis | activates | pathway | 0.60 |
| ALS | associated_with | disease | 0.60 |
| ALS | implicated_in | disease | 0.60 |
| oxidative stress response | participates_in | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| P300 | phosphorylates | protein | 0.90 |
| MST1 | regulates | gene | 0.60 |
| QKI | regulates | gene | 0.60 |
| CTSD | causes | gene | 0.60 |
| ATP13A2 | implicated_in | gene | 0.60 |
| BECN1 | activates | gene | 0.60 |
| CTSD | associated_with | gene | 0.60 |
| AIF1 | interacts_with | gene | 0.60 |
| CTSB | interacts_with | gene | 0.60 |
| CTSD | interacts_with | gene | 0.60 |
| CTSL | interacts_with | gene | 0.60 |
| GFAP | interacts_with | gene | 0.60 |
| IBA1 | interacts_with | gene | 0.60 |
| LAMP1 | interacts_with | gene | 0.60 |
| LAMP2 | interacts_with | gene | 0.60 |
| LC3 | interacts_with | gene | 0.60 |
| LRP1 | interacts_with | gene | 0.60 |
| ALS | implicated_in | gene | 0.60 |
| LC3B | activates | gene | 0.60 |
| ATP | interacts_with | gene | 0.60 |
| LDL | interacts_with | gene | 0.60 |
| MAP1LC3 | interacts_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
immunology | 2026-04-15 | 0 hypotheses
endocrinology | 2026-04-13 | 2 hypotheses Top: 0.572
neurodegeneration | 2026-04-11 | 0 hypotheses
neurodegeneration | 2026-04-11 | 0 hypotheses
neurodegeneration | 2026-04-10 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||